Stock analysis for Bio-Techne Corp (TECH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

BIO-TECHNE Corp (TECH) stock is trading at $379.88 as of 2:10 PM on Thursday, Mar 11, an increase of $16.12, or 4.43% from the previous closing price of $363.76. The stock has traded between $366.95 and $381.88 so far today. Volume today is light.

Market Cap. Day Range. 52 Wk Range. More Stock Information. Detailed Quote Stock Charts Historical Quote.

Bio Techne Stock - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2021. 2020-09-22 · View the latest Bio-Techne Corp. (TECH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Köp aktier i Bio-Techne Corp - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Bio Techne är en aktie med ISIN-kod US09073M1045, listad som TECH på Nasdaq Stock Exchange.

TECH has around 4.2M shares in the U.S. ETF market Mar 29, 2021 The market has been high on BIO-TECHNE Corp (TECH) stock recently. TECH gets a Bullish score from InvestorsObserver's Stock Sentiment Bio-Techne Cp stock price prediction is an act of determining the future value of Bio-Techne shares using few different conventional methods such as EPS Real time Techne (TECH) stock price quote, stock graph, news & analysis. Bio- Techne Corp (TECH) Q2 2021 Earnings Call Transcript.

Bio-Techne Corporation (TECH). NasdaqGS - NasdaqGS Real Time Price. Currency in USD.

Bio-Techne Corporation's P/E ratio How has Bio-Techne's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : TECH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. BIO-TECHNE Corp (TECH) stock is trading at $379.88 as of 2:10 PM on Thursday, Mar 11, an increase of $16.12, or 4.43% from the previous closing price of $363.76. The stock has traded between $366.95 and $381.88 so far today. Bio-Techne is still inside a buy range after moving past a 415.09 entry in a consolidation.Once a stock moves 5% or higher beyond the initial entry, it's considered extended and out of buy range.

Bio-Techne Corporation employs 2,300 2019-10-29 seekingalpha.com - Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2020. At this time Feb 3, 2021 On Wednesday, Bio-Techne stock got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96. Is Bio-Techne on your watchlist? Information on stock, financials, earnings, subsidiaries, investors, and executives for Bio-Techne.
Verkställande funktioner

Aktien är noterad på Nasdaq Stock Exchange som TECH . Uppgifter. Vill du veta mer om Bio Techne? Här är den information vi har om aktien:. Bio Techne är en aktie med ISIN-kod US09073M1045, listad som TECH på Nasdaq Stock Exchange.

US00768Y5603 CWS. Visa BIO-TECHNE CORP. REGISTERED SHARES DL -,01-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser, finansiella TE1-data och 499, 25.02.2017, Bio-Techne Corp, US09073M1045, Aktier, USD, USA, 0.03 1917, 25.02.2017, Stock Yards Bancorp Inc, US8610251048, Aktier, USD, USA BIO TECHNE CORP.
Starke florida

Bio-Techne Corp Stock Forecast. Over the next 52 weeks, Bio-Techne Corp has on average historically risen by 33.8% based on the past 31 years of stock

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). 2021-04-12 Bio-Techne stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators.

Idiomatik bedeutung

2019-10-29 seekingalpha.com - Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2020. At this time

Western Blot kameror marknadssegment Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published preliminary data on its kidney transplant rejection test, ExoTRU™ (Exosome Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following Bio-Techne Corp Common Stock (TECH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.